These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6541101)

  • 21. [Diagnostic and therapeutic experiences with tumors of the urethra and bladder].
    Halász T; Jelen E; Réffy A
    Orv Hetil; 1977 Dec; 118(50):3019-23. PubMed ID: 593684
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythema induced by intra-arterial infusion chemotherapy on the buttock presenting GVHD-like features with marked cellular atypia in histology.
    Demitsu T; Gonda K; Tanita M; Tomita Y
    Dermatology; 1998; 197(1):88-9. PubMed ID: 9711435
    [No Abstract]   [Full Text] [Related]  

  • 23. [Botryoid sarcoma of the urinary bladder in a 3 and a half-year-old boy].
    Pilch J
    Pol Przegl Chir; 1969; 41(4):Suppl 4a:597+. PubMed ID: 5805032
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of x-ray endovascular interventions in the treatment of bladder cancer].
    Anisimov VN; Karelin MI; Tarazov PG
    Vestn Rentgenol Radiol; 1994; (1):43-5. PubMed ID: 7975163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intra-arterial chemotherapy in urological cancer].
    Mitsumori K; Sato K; Kato T
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):197-203. PubMed ID: 11865624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of bladder tumors].
    Njinou B; Dardenne B; Darimont M; Wese FX; Van Cangh PJ
    Acta Urol Belg; 1999; 67(1):6-10. PubMed ID: 10859816
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
    Sylvester RJ
    Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
    [No Abstract]   [Full Text] [Related]  

  • 28. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of bladder neoplasms by instillation of antineoplastic agents].
    Pagliere H; Soldano E; Scorticati C; Franetovich E
    Rev Argent Urol Nefrol; 1965; 34(1):546-51. PubMed ID: 5887917
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intra-arterial chemotherapy for invasive bladder cancer].
    Naito H; Masui M; Imamoto T; Ishiki S; Komiya A; Ito H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1948-50. PubMed ID: 10560433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating bladder cancer: new methods, new management.
    Moore S; Newton M; Grant EG; Keetch DW
    Am J Nurs; 1993 May; 93(5):32-9. PubMed ID: 8488900
    [No Abstract]   [Full Text] [Related]  

  • 32. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
    Soloway MS; Lee CT; Steinberg GD; Ghandi AA; Jewett MA
    Urol Oncol; 2007; 25(4):338-40. PubMed ID: 17628304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intra-arterial chemotherapy in combination with radiotherapy for invasive bladder cancer and prostate cancer].
    Sumiyoshi Y; Hashine K; Nakatsuji H
    Hinyokika Kiyo; 1999 Feb; 45(2):155-8. PubMed ID: 10212792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy.
    Chang SG; Lee SJ; Huh JS; Lee JH
    Oncol Rep; 2001; 8(2):257-61. PubMed ID: 11182036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy.
    Miyanaga N; Akaza H; Hinotsu S; Joraku A; Oikawa T; Sekido N; Kawai K; Shimazui T
    Jpn J Clin Oncol; 2007 Nov; 37(11):852-7. PubMed ID: 17965422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prophylactic intra-arterial chemotherapy for CR patients with invasive bladder cancer after induction therapy].
    Sumiyoshi Y; Hashine K; Kasahara K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1657-9. PubMed ID: 7574786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravesical chemotherapy and immunotherapy: how do we assess their effectiveness and what are their limitations and uses?
    Lamm DL; van der Meijden AP; Akaza H; Brendler C; Hedlund PO; Mizutani Y; Ratliff TL; Robinson MR; Shinka T
    Int J Urol; 1995 Jun; 2 Suppl 2():23-35. PubMed ID: 7553302
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J; Goldberg G
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of bladder cancer with cytostatic agents].
    Steineck G; Wijkström H; Borghede G
    Lakartidningen; 1994 Feb; 91(5):397-404. PubMed ID: 8114569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.